News

Gilead Sciences Inc. Chief Executive Officer Daniel O’Day said the company’s new HIV prevention drug Yeztugo should be able ...
Intel shares rose nearly 3% on Friday on hopes of more financial aid for the turnaround of the struggling chipmaker after a ...